We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.07%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$39.1B
AUM Growth
+$5.57B
(+17%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
25.2%
Holding
834
New
111
Increased
262
Reduced
309
Closed
110
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$2.28B |
| 2 |
Otis Worldwide
OTIS
|
+$193M |
| 3 |
Burlington
BURL
|
+$191M |
| 4 |
AbbVie
ABBV
|
+$178M |
| 5 |
Wayfair
W
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Lockheed Martin
LMT
|
+$339M |
| 3 |
Johnson & Johnson
JNJ
|
+$262M |
| 4 |
Pfizer
PFE
|
+$167M |
| 5 |
Target
TGT
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.52% |
| 2 | Healthcare | 19.78% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Financials | 11.33% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Clorox
CLX
$12.6B
| $31.8M | 0.08% |
144,853
+3,600
| +3% | +$719K |
|
277
Agilent Technologies
A
$39.8B
| $31.6M | 0.08% |
357,706
+5,588
| +2% | +$458K |
|
278
Deere & Co
DE
$166B
| $31.2M | 0.08% |
198,826
-435,003
| -69% | -$63M |
|
279
American International
AIG
$42.3B
| $31M | 0.08% |
994,321
-16,400
| -2% | -$460K |
|
280
Vale
VALE
$63.3B
| $30.9M | 0.08% |
+3,000,000
| New | +$27.5M |
|
281
GE Aerospace
GE
$395B
| $30.9M | 0.08% |
908,302
+110,236
| +14% | +$3.72M |
|
282
MetLife
MET
$61.7B
| $30.9M | 0.08% |
846,326
+45,800
| +6% | +$1.59M |
|
283
Chipotle Mexican Grill
CMG
$44.3B
| $30.8M | 0.08% |
1,462,100
+82,100
| +6% | +$1.52M |
|
284
Hyliion Holdings
HYLN
$728M
| $30.6M | 0.08% |
1,116,350
-908,650
| -45% | -$11M |
|
285
Eversource Energy
ES
$27.3B
| $30.6M | 0.08% |
367,582
-3,400
| -0.9% | -$282K |
|
286
Leggett & Platt
LEG
$1.42B
| $30.4M | 0.08% |
+865,021
| New | +$26.8M |
|
287
Yum! Brands
YUM
$41.6B
| $30.1M | 0.08% |
345,791
-777
| -0.2% | -$66.4K |
|
288
Monster Beverage
MNST
$92.4B
| $29.9M | 0.08% |
861,322
-14,400
| -2% | -$470K |
|
|
ORBC
289
DELISTED
ORBCOMM, Inc.
ORBC
| $29.7M | 0.08% |
7,715,141
-46,410
| -0.6% | -$139K |
|
290
Generac Holdings
GNRC
$13.3B
| $29.6M | 0.08% |
+242,821
| New | +$25.6M |
|
291
HCA Healthcare
HCA
$88.9B
| $29.6M | 0.08% |
304,800
+1,400
| +0.5% | +$146K |
|
292
Kura Oncology
KURA
$826M
| $29.5M | 0.08% |
1,809,450
+1,259,450
| +229% | +$18.2M |
|
293
Aflac
AFL
$63.5B
| $29.4M | 0.08% |
816,974
-13,200
| -2% | -$477K |
|
294
Champion Homes
SKY
$5B
| $29.4M | 0.08% |
1,208,572
-606,035
| -33% | -$12.6M |
|
295
Sysco
SYY
$40.6B
| $29.4M | 0.08% |
537,924
+22,700
| +4% | +$1.19M |
|
|
FISV
296
Fiserv Inc
FISV
$28.9B
| $29.1M | 0.07% |
298,231
+272,000
| +1,037% | +$27.4M |
|
|
ANSS
297
DELISTED
Ansys
ANSS
| $29M | 0.07% |
99,500
+3,400
| +4% | +$905K |
|
298
IQVIA
IQV
$38.9B
| $28.9M | 0.07% |
203,800
-3,200
| -2% | -$434K |
|
299
Phillips 66
PSX
$81B
| $28.8M | 0.07% |
400,056
+86,900
| +28% | +$6.15M |
|
300
McKesson
MCK
$99.3B
| $28.7M | 0.07% |
186,960
+1,900
| +1% | +$274K |
|
Similar funds
Adage Capital Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Adage Capital Partners held 834 positions worth $39.1B, up 17% from $33.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Adage Capital Partners withdrew a net $1.33B in Q2 2020, closing 110 positions and reducing 309 holdings. Its most notable exit was Allergan plc, an estimated $1.66B position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Royalty Pharma worth $2.23B.
- Adage Capital Partners's largest Q2 2020 buy was Royalty Pharma: 46,015,330 shares worth $2.23B.
- Adage Capital Partners added most to Burlington in Q2 2020, an estimated $191M increase.
- Adage Capital Partners's biggest Q2 2020 reduction was Lockheed Martin, cutting an estimated $339M.
- Adage Capital Partners fully exited Allergan plc in Q2 2020, selling an estimated $1.66B.
- Adage Capital Partners's ten largest holdings make up 25% of its $39.1B portfolio in Q2 2020.
- Adage Capital Partners opened 111 new positions and closed 110 in Q2 2020.
- Adage Capital Partners's portfolio value rose 17% quarter-over-quarter to $39.1B.
Based on Adage Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.